DD204924A5 - Verfahren zur herstellung n-substituierter 2-pyridylindole - Google Patents
Verfahren zur herstellung n-substituierter 2-pyridylindole Download PDFInfo
- Publication number
- DD204924A5 DD204924A5 DD82244959A DD24495982A DD204924A5 DD 204924 A5 DD204924 A5 DD 204924A5 DD 82244959 A DD82244959 A DD 82244959A DD 24495982 A DD24495982 A DD 24495982A DD 204924 A5 DD204924 A5 DD 204924A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- pyridyl
- formula
- compound
- methyl
- indole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32301881A | 1981-11-19 | 1981-11-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
DD204924A5 true DD204924A5 (de) | 1983-12-14 |
Family
ID=23257445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD82244959A DD204924A5 (de) | 1981-11-19 | 1982-11-17 | Verfahren zur herstellung n-substituierter 2-pyridylindole |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP0080154B1 (xx) |
JP (1) | JPS5892677A (xx) |
KR (1) | KR880002010B1 (xx) |
AR (3) | AR241428A1 (xx) |
AT (1) | ATE15196T1 (xx) |
AU (1) | AU564233B2 (xx) |
CA (1) | CA1197249A (xx) |
DD (1) | DD204924A5 (xx) |
DE (1) | DE3265892D1 (xx) |
DK (1) | DK169104B1 (xx) |
ES (4) | ES517439A0 (xx) |
FI (1) | FI75344C (xx) |
GB (1) | GB2111050B (xx) |
GR (1) | GR77035B (xx) |
HU (1) | HU190425B (xx) |
IE (1) | IE54156B1 (xx) |
IL (1) | IL67284A (xx) |
NO (1) | NO159929C (xx) |
NZ (1) | NZ202551A (xx) |
PH (1) | PH19212A (xx) |
PT (1) | PT75870B (xx) |
ZA (1) | ZA828505B (xx) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4511573A (en) * | 1983-05-17 | 1985-04-16 | Ciba-Geigy Corporation | 3-Substituted-2-(heteroaryl) indoles |
GB8524157D0 (en) * | 1984-10-19 | 1985-11-06 | Ici America Inc | Heterocyclic amides |
US4675332A (en) * | 1984-12-10 | 1987-06-23 | Warner-Lambert Company | Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents |
US4609733A (en) * | 1984-12-27 | 1986-09-02 | Ciba-Geigy Corporation | 3-keto-substituted-N-pyridylindoles |
GB8626296D0 (en) * | 1986-11-04 | 1986-12-03 | Ici Plc | Therapeutic agents |
GB8626297D0 (en) * | 1986-11-04 | 1986-12-03 | Ici Plc | Pharmaceutical compositions |
GB9319100D0 (en) * | 1993-09-15 | 1993-11-03 | Pfizer Ltd | 3-(3-pyridinyl)h-indoles |
CA2140722A1 (en) * | 1994-01-24 | 1995-07-25 | Joseph A. Jakubowski | Beta-carboline thromboxane synthase inhibitors |
US6828344B1 (en) * | 1998-02-25 | 2004-12-07 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
GB0307891D0 (en) * | 2003-04-04 | 2003-05-14 | Angeletti P Ist Richerche Bio | Chemical compounds,compositions and uses |
AR072297A1 (es) * | 2008-06-27 | 2010-08-18 | Novartis Ag | Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona. |
ES2927960T3 (es) * | 2017-12-15 | 2022-11-14 | Bristol Myers Squibb Co | Compuestos de indol éter sustituidos |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3468894A (en) * | 1966-11-29 | 1969-09-23 | Geigy Chem Corp | Certain 2-pyridyl-substituted indole derivatives |
DE2909779A1 (de) * | 1979-03-13 | 1980-09-18 | Thomae Gmbh Dr K | Neue indolderivate, deren herstellung und deren verwendung als arzneimittel |
-
1982
- 1982-11-12 GB GB08232457A patent/GB2111050B/en not_active Expired
- 1982-11-16 AT AT82110582T patent/ATE15196T1/de active
- 1982-11-16 EP EP82110582A patent/EP0080154B1/de not_active Expired
- 1982-11-16 DE DE8282110582T patent/DE3265892D1/de not_active Expired
- 1982-11-17 PH PH28151A patent/PH19212A/en unknown
- 1982-11-17 IL IL67284A patent/IL67284A/xx not_active IP Right Cessation
- 1982-11-17 FI FI823938A patent/FI75344C/fi not_active IP Right Cessation
- 1982-11-17 CA CA000415716A patent/CA1197249A/en not_active Expired
- 1982-11-17 GR GR69837A patent/GR77035B/el unknown
- 1982-11-17 ES ES517439A patent/ES517439A0/es active Granted
- 1982-11-17 DD DD82244959A patent/DD204924A5/de not_active IP Right Cessation
- 1982-11-18 ZA ZA828505A patent/ZA828505B/xx unknown
- 1982-11-18 DK DK514182A patent/DK169104B1/da not_active IP Right Cessation
- 1982-11-18 HU HU823704A patent/HU190425B/hu not_active IP Right Cessation
- 1982-11-18 NZ NZ202551A patent/NZ202551A/xx unknown
- 1982-11-18 PT PT75870A patent/PT75870B/pt not_active IP Right Cessation
- 1982-11-18 AU AU90675/82A patent/AU564233B2/en not_active Ceased
- 1982-11-18 IE IE2749/82A patent/IE54156B1/en not_active IP Right Cessation
- 1982-11-18 NO NO823869A patent/NO159929C/no unknown
- 1982-11-19 AR AR82291366A patent/AR241428A1/es active
- 1982-11-19 KR KR8205232A patent/KR880002010B1/ko not_active IP Right Cessation
- 1982-11-19 JP JP57203514A patent/JPS5892677A/ja active Granted
-
1984
- 1984-02-28 ES ES530127A patent/ES8608508A1/es not_active Expired
- 1984-02-28 ES ES530128A patent/ES530128A0/es active Granted
- 1984-02-28 ES ES530126A patent/ES530126A0/es active Granted
- 1984-11-07 AR AR84298532A patent/AR243519A1/es active
- 1984-11-07 AR AR84298531A patent/AR243177A1/es active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69725978T2 (de) | Chalcon-derivate und medikamente die diese enthalten | |
DE69705324T2 (de) | N-hydroxyharnstoffderivate und sie enthaltende medizinische zubereitungen | |
EP0022078B1 (de) | Pyrazolochinoline, Verfahren zu ihrer Herstellung, und pharmazeutische Präparate enthaltend diese Verbindungen | |
US5128343A (en) | Derivatives of pyrimidinyl-piperazinyl-alkyl azoles with anxiolytic and/or tranquilizing activity | |
EP0080154B1 (de) | N-Substituierte 2-Pyridylindole, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie ihre therapeutische Verwendung | |
US4478842A (en) | N-Substituted-2-pyridylindoles | |
DD224588A5 (de) | Verfahren zur herstellung von n-pyridylindolen | |
DE69217308T2 (de) | Dihydropyridine zur Anwendung in der Antitumor-Therapie | |
EP0114573B1 (de) | Imidazo(1,5-a)pyridin-Derivate | |
EP0068386B1 (de) | Substituierte Imidazo(1,5-a)pyridine, Verfahren zu ihrer Herstellung und pharmazeutische Präparate die diese Verbindungen enthalten | |
EP0107618B1 (en) | N-substituted-2-(1-imidazolyl)-indoles | |
EP0129051B1 (de) | Substituierte Indole | |
DE69104481T2 (de) | Imidazo[4,5-c]pyridine als paf antagonisten. | |
DE3306146A1 (de) | Pyridin-derivate und ihre verwendung als arzneimittel | |
EP0114572A1 (de) | Substituierte Imidazo(1,5-a)pyridine | |
US4551460A (en) | Pyrido[2,1-b]quinazoline derivatives useful as agents for treatment of allergic conditions and vascular disorders involving thrombosis | |
US4460777A (en) | N-Substituted-2-pyridylindoles | |
US4639521A (en) | Isoquinoline derivatives | |
US4539410A (en) | N-Substituted-2-(1-imidazolyl)indoles | |
US4294969A (en) | Process for producing 2-bromo-3,5-disubstituted pyridines | |
US4279913A (en) | Polysubstituted-2-(3-loweralkylamino-2-R1 O-propoxy)pyridines | |
JPH0625250A (ja) | チエノ〔3,4−d〕イミダゾール誘導体、その製造法およびそれを含有する循環器官用剤 | |
DE68920168T2 (de) | 2-Substituierte Carbonylimidazo[4,5-c]chinoline. | |
DE69005833T2 (de) | Entzündungshemmende 1-Heteroaryloxindole-3-Carboxamide. | |
DD202572A5 (de) | Verfahren zur herstellung von neuen imidazo (1,5-a)-pyridinen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENJ | Ceased due to non-payment of renewal fee |